1. REPORT
2. INFORMATION ABOUT THE ENTITY
3. SIGNATURE OF PERSONS REPRESENTING THE COMPANY
Spis załączników:
POLISH FINANCIAL SUPERVISION AUTHORITY |
|||||||||||
|
UNI - EN REPORT No |
50 | / |
2025 |
|
||||||
Date of issue: |
2025-11-21 |
||||||||||
Short name of the issuer |
|||||||||||
KRKA |
|||||||||||
Subject |
|||||||||||
Acquisition of treasury shares |
|||||||||||
Official market - legal basis |
|||||||||||
Unofficial market - legal basis |
|||||||||||
Contents of the report: |
|||||||||||
Based on the provisions of the Rules of the Ljubljana Stock Exchange, d. d., Ljubljana and Article 2 of the Commission Delegated Regulation (EU) 2016/1052 Krka, d. d., Novo mesto announces: With a reference to the public notice from 20 July 2023, Krka is publicly disclosing information on transactions relating to buy-back programme in the period from 14 November 2025 up to and including 20 November 2025. Krka acquired 4,964 treasury shares in the total value of EUR 1,023,351 on the Ljubljana Stock Exchange as follows: - on 14 November 2025: 1,208 shares at a VWAP of EUR 206.72, - on 17 November 2025: 950 shares at a VWAP of EUR 206.35, - on 18 November 2025: 1,163 shares at a VWAP of EUR 205.63, - on 19 November 2025: 552 shares at a VWAP of EUR 206.00 and - on 20 November 2025: 1,091 shares at a VWAP of EUR 206.00. Price is calculated as volume weighted average price (VWAP). Ilirika d.d., Intercapital d.d. and NLB d.d. were brokers in these transactions. Detailed report on acquisition of treasury shares attached. The total number of treasury shares prior to these transactions was 2,409,488 representing 7.347% of all shares issued. The total number of treasury shares after these transactions is 2,414, 452 representing 7.363% of all shares issued. The notice will be published on the Company's website (www.krka.biz) from 21 November 2025 onwards, for a minimum period of 5 years. |
|||||||||||
Annexes |
|||||||||||
File |
Description |
||||||||||
Detailed report on acquisition of treasury shares |
|||||||||||
KRKA, TOVARNA ZDRAVIL D.D. |
|||||||||||||
(fullname of the issuer) |
|||||||||||||
KRKA |
Farmaceutyczny (far) |
||||||||||||
(short name of the issuer) |
(sector according to clasification of the WSE in Warsow) |
||||||||||||
8501 |
Nove Mesto |
||||||||||||
(post code) |
(city) |
||||||||||||
Smarjeska |
6 | ||||||||||||
(street) |
(number) |
||||||||||||
+386 7 331 21 11 |
+386 7 332 15 37 |
||||||||||||
(phone number) |
(fax) |
||||||||||||
(e-mail) |
(web site) |
||||||||||||
nie dotyczy |
|||||||||||||
(NIP) |
(REGON) |
||||||||||||
SIGNATURE OF PERSONS REPRESENTING THE COMPANY |
|||||
Date |
Name |
Position / Function |
Signature |
||
2025-11-21 |
Jože Colarič |
President of the Management Board and CEO |
|||